GlobeNewswire Inc.··NaSagimet Biosciences Names Veteran Pharma Executive Andreas Grauer as CMO
Sagimet Biosciences appoints Dr. Andreas Grauer as Chief Medical Officer, replacing retiring Dr. Eduardo Martins. Grauer joins from senior roles at Amgen and Corcept, receiving $1.34M in stock options.
AMGNSGMTOMERexecutive leadershipstock option grant